Embecta Corp (STU:JX7)
€ 19.4 0 (0%) Market Cap: 1.14 Bil Enterprise Value: 2.41 Bil PE Ratio: 15.43 PB Ratio: 0 GF Score: 27/100

Embecta Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 05:45PM GMT
Release Date Price: €22.4 (-1.75%)
Caroline Borowski

Welcome to the JPMorgan Healthcare Conference Day 3. My name is Caroline Borowski, and I'm an associate here at the JPMorgan Healthcare Group. It is my pleasure to introduce Dev Kurdikar, President and CEO of Embecta.

Devdatt Kurdikar
Embecta Corp. - President, CEO & Director

Thank you, Caroline. It's an absolute pleasure for us to be here. This is our first JPMorgan Healthcare Conference as our own independent company, and it's truly a thrill, especially because in our first year, we are back in person now after being virtual for a number of years. With me today, I have Jake Elguicze, our Chief Financial Officer; Pravesh Khandelwal, is sitting there. He is our Head of our Investor Relations. Our plan is to take about 20 minutes just to give you a strategy and business update. And then I'm sure we'll have time for questions. This is our forward-looking statement language. Let me first start, given that we are a new company, let me just first start by sort of emphasizing who we are.

Our mission is to develop and provide solutions for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot